I just clicked on the link and I don’t think I’ve ever seen anything like it before. I assume there was no cc and the company went ahead and disclosed a (rather unflattering) scripted Q and A related to the top line results. I mean why even hedge like that on the clinical significance of the trial unless you are softening up investors ahead of bad news once you present the full data and or discussions with regulators.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.